127 related articles for article (PubMed ID: 11578010)
1. D-penicillamine is not an effective treatment in systemic sclerosis.
Furst DE; Clements PJ
Scand J Rheumatol; 2001; 30(4):189-91. PubMed ID: 11578010
[TBL] [Abstract][Full Text] [Related]
2. D-penicillamine in systemic sclerosis? Yes!
Medsger TA; Lucas M; Wildy KS; Baker C
Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
[TBL] [Abstract][Full Text] [Related]
3. Penicillamine in the treatment of systemic sclerosis.
Clements PJ
Curr Rheumatol Rep; 1999 Oct; 1(1):38-42. PubMed ID: 11123013
[TBL] [Abstract][Full Text] [Related]
4. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Clements PJ; Seibold JR; Furst DE; Mayes M; White B; Wigley F; Weisman MD; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Wong WK
Semin Arthritis Rheum; 2004 Feb; 33(4):249-63. PubMed ID: 14978663
[TBL] [Abstract][Full Text] [Related]
5. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
6. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
[TBL] [Abstract][Full Text] [Related]
7. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
[No Abstract] [Full Text] [Related]
8. Clinical trials for the treatment of systemic sclerosis/scleroderma.
Varga J; Ponor I
Curr Rheumatol Rep; 1999 Oct; 1(1):13-4. PubMed ID: 11123008
[No Abstract] [Full Text] [Related]
9. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.
Boehler A; Vogt P; Speich R; Weder W; Russi EW
Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954
[TBL] [Abstract][Full Text] [Related]
10. The use of penicillamine in the treatment of rheumatoid arthritis and scleroderma.
Baum J
Scand J Rheumatol Suppl; 1979; (28):65-70. PubMed ID: 377472
[TBL] [Abstract][Full Text] [Related]
11. [D-penicillamine: an outdated cure for systemic scleroderma?].
Marie I; Lévesque H; Courtois H
Rev Med Interne; 1999 Dec; 20(12):1077-81. PubMed ID: 10635068
[No Abstract] [Full Text] [Related]
12. The toxicity of D-penicillamine in systemic sclerosis.
Steen VD; Blair S; Medsger TA
Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
[TBL] [Abstract][Full Text] [Related]
13. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
Strand V
Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222
[No Abstract] [Full Text] [Related]
14. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
Zvulunov A; Grunwald MH; Avinoach I; Halevy S
Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901
[No Abstract] [Full Text] [Related]
15. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
16. A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset.
Derk CT; Huaman G; Jimenez SA
Br J Dermatol; 2008 May; 158(5):1063-8. PubMed ID: 18284395
[TBL] [Abstract][Full Text] [Related]
17. Penicillamine in systemic sclerosis: a reappraisal.
Sattar MA; Guindi RT; Sugathan TN
Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
Shapiro M; Jimenez S; Werth VP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
[TBL] [Abstract][Full Text] [Related]
19. Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
Khanna D; Furst DE; Hays RD; Park GS; Wong WK; Seibold JR; Mayes MD; White B; Wigley FF; Weisman M; Barr W; Moreland L; Medsger TA; Steen VD; Martin RW; Collier D; Weinstein A; Lally EV; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Ann Rheum Dis; 2006 Oct; 65(10):1325-9. PubMed ID: 16540546
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of systemic sclerosis].
van den Hoogen FH
Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
